
NEWS & PRESS
Solarea Bio Teams up with Hebrew SeniorLife Investigators on a Newly Awarded U.S. National Academy of Medicine Catalyst Grant
Solarea Bio and leading researchers at Harvard Medical School affiliated Hebrew SeniorLife, New England’s largest nonprofit provider of senior health care and living communities, are co-investigators on a competitive research grant from the U.S. National Academy of Medicine’s …
Nov 04 2021
Solarea Bio Announces Licensing Agreement with ADM
Solarea Bio, a biotech company based in Cambridge, MA that is developing microbial-based solutions to aid human health, today announced it has signed a technology licensing agreement with global nutrition leader ADM.
Oct 19 2021
Solarea Bio rounds out management team to gear up for commercialization of first product
Solarea Bio, a company launching microbiome products to combat inflammatory conditions and improve the lives of afflicted individuals, rounds out their management team with strong startup commercialization experience as they welcome Dr. David Easson, Chief Manufacturing Officer and …
Oct 07 2021
Welcome Solarea Bio: Innovators Unlocking the Power of Microbes to Improve Human Health
S2G’s investment into Solarea provides an opportunity for S2G to support the next wave of functional foods. S2G’s led Solarea’s Series A fundraise with Bold Capital Partners, along with continued investment from Viking Global Investors and the Gisev …
Oct 19 2020